data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
uniQure
(NASDAQ:QURE)
18.99
-0.12[-0.63%]
Last update: 2:43PM
15 minutes delayed
Day High/Low18.54 - 19.09
52 Week High/Low12.52 - 38.8
Open / Close18.99 / -
Float / Outstanding46.3M / 46.6M
Vol / Avg.483K / 634.6K
Mkt Cap885.8M
P/E2.75
50d Avg. Price15.08
Div / Yield-
Payout Ratio-
EPS-1
Total Float46.3M

uniQure (NASDAQ:QURE), Quotes and News Summary

uniQure (NASDAQ: QURE)

Day High/Low18.54 - 19.09
52 Week High/Low12.52 - 38.8
Open / Close18.99 / -
Float / Outstanding46.3M / 46.6M
Vol / Avg.483K / 634.6K
Mkt Cap885.8M
P/E2.75
50d Avg. Price15.08
Div / Yield-
Payout Ratio-
EPS-1
Total Float46.3M
Benzinga - 3 days ago
Benzinga - 4 days ago
Benzinga - 4 days ago
Benzinga - 4 days ago
Benzinga - Jun 13, 2022, 11:41AM
Benzinga - May 24, 2022, 10:07AM
Benzinga - May 24, 2022, 8:01AM
Benzinga - May 3, 2022, 9:41AM
Benzinga - May 3, 2022, 5:02AM
Benzinga - May 2, 2022, 7:11AM
Benzinga - Mar 21, 2022, 7:06AM
Benzinga - Mar 17, 2022, 8:03AM
Benzinga - Mar 2, 2022, 7:21AM
Benzinga - Feb 25, 2022, 7:18AM
Benzinga - Feb 7, 2022, 7:08AM
Benzinga - Dec 17, 2021, 4:34AM
Benzinga - Dec 16, 2021, 2:45PM
Benzinga - Dec 16, 2021, 1:10PM
load more
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-25
REV
Q1 2022Est.ActualSurprise
EPS-0.930-1.000 -0.0700
REV19.220M1.792M-17.428M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

uniQure Questions & Answers

Q
How do I buy uniQure (QURE) stock?
A

You can purchase shares of uniQure (NASDAQ: QURE) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are uniQure's (QURE) competitors?
A

There are no as such competitors for uniQure.

Q
What is the target price for uniQure (QURE) stock?
A

The latest price target for uniQure (NASDAQ: QURE) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 51.00 expecting QURE to rise to within 12 months (a possible 168.56% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for uniQure (QURE)?
A

The stock price for uniQure (NASDAQ: QURE) is $18.99 last updated Today at June 27, 2022, 6:43 PM UTC.

Q
Does uniQure (QURE) pay a dividend?
A

There are no upcoming dividends for uniQure.

Q
When is uniQure (NASDAQ:QURE) reporting earnings?
A

uniQure’s Q2 earnings are confirmed for Monday, July 25, 2022.

Q
Is uniQure (QURE) going to split?
A

There is no upcoming split for uniQure.

Q
What sector and industry does uniQure (QURE) operate in?
A

uniQure is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.